Basic Tumor Immunology

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
Dominique N Lisiero, Horacio Soto, Richard G Everson, Linda M Liau, Robert M Prins

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 8; DOI: 10.1186/2051-1426-2-8
Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
By Gan Zhao, John P Vasilakos, Debra Tross, Dmitri Smirnov, Dennis M Klinman

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 12; DOI: 10.1186/2051-1426-2-12
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
Minghui Li, Aaron R Bolduc, Md Nasrul Hoda, Denise N Gamble, Sarah-Bianca Dolisca, Anna K Bolduc, Kelly Hoang, Claire Ashley, David McCall, Amyn M Rojiani, Bernard L Maria, Olivier Rixe, Tobey J MacDonald, Peter S Heeger, Andrew L Mellor, David H Munn, Theodore S Johnson

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 21; DOI: 10.1186/2051-1426-2-21
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
Rachel E Beard, Zhili Zheng, Kiran H Lagisetty, William R Burns, Eric Tran, Stephen M Hewitt, Daniel Abate-Daga, Shannon F Rosati, Howard A Fine, Soldano Ferrone, Steven A Rosenberg, Richard A Morgan

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 25; DOI: 10.1186/2051-1426-2-25
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8⁺ T cells
Michael J McNamara, Melissa J Kasiewicz, Stefanie N Linch, Christopher Dubay, William L Redmond

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 28; DOI: 10.1186/s40425-014-0028-y
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean-Pierre Mach, Pedro Romero, Alena Donda

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 39; DOI: 10.1186/s40425-014-0039-8
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
Karsten A Pilones, Joseph Aryankalayil, James S Babb, Sandra Demaria

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 37; DOI: 10.1186/s40425-014-0037-x
4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39⁺ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
Galam Leem, Junsik Park, Minwoo Jeon, Eui-Soon Kim, Sang Wun Kim, Yong Jae Lee, Seong Jin Choi, Baekgyu Choi, Seongyeol Park, Young Seok Ju, Inkyung Jung, Sunghoon Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001650; DOI: 10.1136/jitc-2020-001650
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma
Weinan Guo, Jinyuan Ma, Sen Guo, Huina Wang, Sijia Wang, Qiong Shi, Lin Liu, Tao Zhao, Fengfan Yang, Shuyang Chen, Jianru Chen, Jianhong Zhao, Chen Yu, Xiuli Yi, Yuqi Yang, Jingjing Ma, Qingrong Ni, Guannan Zhu, Tianwen Gao, Chunying Li

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001866; DOI: 10.1136/jitc-2020-001866
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
Carolina Tiraboschi, Lucas Gentilini, Carla Velazquez, Enrique Corapi, Felipe Martín Jaworski, José Daniel Garcia Garcia, Yorfer Rondón, Anne Chauchereau, Diego José Laderach, Daniel Compagno

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001535; DOI: 10.1136/jitc-2020-001535

Main menu

Basic Tumor Immunology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Basic Tumor Immunology

Pages